🔍 Observations
Topline
- Net Interest Income (NII) expanded modestly — interest earned grew 4.8% YoY in Q4 (₹49,594 Cr vs ₹48,387 Cr), while interest expended fell 4.3% YoY, expanding the spread meaningfully.
- Total income for FY2026 reached ₹3,12,118 Cr (+5.9% YoY), driven by loan book growth and stable investment yields.
- Other income (non-insurance) grew 5.2% YoY in FY2026 to ₹39,276 Cr — fee income resilience holds.
Bottomline
- Q4 PAT surged 9.3% YoY to ₹14,755 Cr and 17.7% QoQ — clean, no exceptional items distorting the print.
- FY2026 PAT of ₹54,208 Cr grew 6.2% YoY, with minority interest absorption (₹3,729 Cr) muting consolidated headline growth vs. standalone.
- Diluted EPS rose to ₹74.77 for FY2026 vs ₹71.14 — 5.1% growth, modest given the PAT trajectory; equity dilution via ESOPs is a marginal drag.
Margins
- Operating profit grew 6.3% YoY in FY2026 (₹82,696 Cr vs ₹77,759 Cr) — operating leverage is present but not dramatic.
- Provisions collapsed in Q4 to ₹261 Cr vs ₹2,647 Cr in Q3 — suggests meaningful write-back or asset quality improvement; FY2026 provisions of ₹5,639 Cr up 15% YoY warrants watching.
- Effective tax rate held steady ~25% — no deferred tax distortions skewing net margin.
Growth Trajectory
- Advances grew 15.8% YoY (₹16,44,658 Cr vs ₹14,20,664 Cr) — loan growth outpacing deposit growth of 11.5%, tightening the CD ratio.
- FY2026 PAT CAGR is modest at ~6%, indicating the bank is in a consolidation phase post the hyper-growth cycle.
- Insurance premium income grew 9.5% YoY in FY2026 — ICICI Life/General subsidiaries remain steady compounders within the group.
🧮 Profit & Loss Statement
🧮 Balance Sheet
🧮 Cash Flows Statement
🟢 Green Flags
- Q4 provisions at ₹261 Cr (vs ₹2,647 Cr in Q3) signals acute improvement in asset quality — credit cost trajectory is turning favourable.
- NII spread expansion — interest earned grew 2.5% QoQ while interest expended rose only 0.8% QoQ, indicating pricing power and repricing tailwinds.
- Zero exceptional items across all periods — earnings quality is high; PAT is entirely from ordinary operations.
- Advances growth of 15.8% YoY with a diversified book supports durable revenue compounding ahead.
- Reserves grew 16% YoY to ₹3,58,946 Cr — capital buffer is strong, limiting near-term equity dilution risk.
- Other income (non-insurance) at ₹39,276 Cr in FY2026 reflects consistent fee, forex, and treasury contribution — revenue stream diversification is a structural positive.
- Share of associate profits nearly doubled YoY (₹263 Cr vs ₹151 Cr) — ICICI Prudential AMC and others increasingly contributing.
🔴 Red Flags
- Loan-to-deposit gap widening — advances grew 15.8% vs deposit growth of 11.5%; if deposit mobilisation slows, funding cost pressure builds.
- FY2026 provisions up 15% YoY — while Q4 saw a collapse, the full-year trend shows credit costs are structurally higher than FY2025 levels.
- Insurance operating expenses surged — claims and benefits paid hit ₹81,836 Cr in FY2026 vs ₹73,806 Cr (+10.9% YoY), compressing insurance subsidiary margins.
- Other liabilities and provisions ballooned to ₹1,88,143 Cr (+18.6% YoY) — needs monitoring; a portion likely relates to insurance policyholder obligations but the rise is steep.
- Diluted EPS growth of 5.1% YoY significantly lags PAT growth of 6.2% — ongoing ESOP dilution is eroding per-share value creation.
- Operating cash generation near-zero — net cash from operations (ex working capital) effectively neutral at -₹56 Cr in FY2026, a sharp reversal from ₹64,018 Cr in FY2025 — driven by aggressive loan disbursements.
📊 Balance Sheet Quality Assessment
- Capital adequacy buffer is robust — reserves at ₹3,59K Cr with minority interest of ₹16,511 Cr providing group-level cushion.
- Investments declined ₹15,657 Cr YoY to ₹8,70,720 Cr — suggests deliberate rotation from securities into higher-yielding loans; a positive for NIM but increases duration risk in a volatile rate environment.
- Liquidity position strengthened — balances with banks and money at call more than doubled to ₹1,43,744 Cr; liquid asset buffer is substantial.
- Borrowings nearly flat YoY (₹2,20,264 Cr vs ₹2,18,883 Cr) — no incremental leverage stress at the holding company level.
💰 Cash Flow Analysis
- Operating CF of ₹67,325 Cr is optically healthy but almost entirely driven by working capital items (deposit inflows ₹1,88,380 Cr offset by loan disbursements -₹2,30,271 Cr) — the underlying business cash generation is thin.
- Investing outflow of ₹13,014 Cr is significantly lower than FY2025’s ₹77,288 Cr — HTM securities purchases dropped sharply, freeing up capital for lending.
- Financing CF negative at -₹4,661 Cr — net borrowing repayments and dividend outflow (₹7,853 Cr) exceed fresh capital raised; a healthy deleveraging signal.
- Cash and equivalents at ₹2,64,981 Cr (up from ₹2,14,023 Cr) — group liquidity is at a multi-year high, providing a strong buffer against funding shocks.
💡 Investment Outlook
ICICI Bank delivered a clean, high-quality Q4 with PAT growth of 9.3% YoY and negligible provisioning — an operationally strong close to FY2026.
Loan book growth at 15.8% is healthy, but the widening credit-deposit gap and near-zero operating cash generation signal the bank is consuming capital to grow.
At current EPS trajectory (~5-6% growth), valuation comfort depends on the thesis that credit costs have peaked and NIM will stabilise — both of which the Q4 data tentatively support.
Monitor deposit mobilisation and FY2027 credit cost trajectory before increasing exposure.
Disclaimer: This post features ChartAlert-AI-generated financial content which may contain inaccuracies or errors. This commentary is strictly for informational purposes and does not constitute a recommendation to buy or sell any security. Investors are responsible for performing their own due diligence; always consult with a licensed financial advisor before making investment decisions.
Beyond the Price Action: Fundamental Analysis is Coming to ChartAlert
ChartAlert is evolving into integrated research with a future update that will embed fundamental data into your workflow. Alongside technical analysis, the new release will allow access to financial spreadsheets, quarterly results review, earnings call transcripts, and valuation tools, connecting price action with corporate performance for smarter, data‑driven decisions.